Overview

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

Status:
Completed

Trial end date:
2019-01-31

Target enrollment:

Participant gender:

Summary

The present study was designed to determine whether or not darbepoetin alfa is non-inferior to recombinant human erythropoietin in the treatment of anemia in children with chronic kidney disease stage 3-5 (on or not on dialysis).

Phase:

Phase 4

Details

Lead Sponsor:

Rufaida Mazahir

Treatments:

Darbepoetin alfa
Epoetin Alfa